DAWN FY 2022 Earnings — Day One Biopharmaceuticals, Inc. Revenue & Financial Results | Market Cap Arena

DAWNDay One Biopharmaceuticals, Inc.

$2B

FY 2022 Earnings

Healthcare Biotechnology

Income Statement

Revenue

$0

Gross Profit

-$531,000

Operating Income

-$147M

Net Income

-$142M

EPS (Diluted)

$-2.02

Cash Flow

Operating Cash Flow

-$110M

Free Cash Flow

-$110M

Stock-Based Comp.

$27M

Balance Sheet

Total Assets

$349M

Total Liabilities

$17M

Stockholders' Equity

$332M

Cash & Equivalents

$85M

Year-over-Year Comparison

Metric	Current	Year Ago	Change
Revenue	$0	$0	—
Gross Profit	-$531,000	-$199,000	-166.8%
Operating Income	-$147M	-$73M	-102.0%
Net Income	-$142M	-$71M	-101.3%